News
New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...
In comments posted in response to the Trump administration’s pharma tariff investigation, companies and industry groups ...
Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase ...
(Alliance News) - Hutchmed China Ltd on Monday said its combination therapy for a specific form of advanced lung cancer significantly delayed disease progression compared to chemotherapy, based on ...
Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of Tempus One?its generative AI clinical assistant?with ...
Danaher Corporation ("Danaher"), a global science and technology innovator, announced today the launch of a partnership with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and commercialize novel ...
Last week, the Trump Administration's FTC and DOJ (Antitrust Division) filed a statement of interest in support of a lawsuit ...
Lerzan Aksoy is dean, George N. Jean Ph.D. chair and professor of marketing at Fordham University’s Gabelli School of ...
The global Generic Pharmaceuticals Market size is projected to be valued at USD 391.5 billion in 2023 and reach USD 682.9 ...
In an interview, Prof Martin Dreyling discussed the approval of first-line acalabrutinib for the treatment of adult patients ...
(4) It generates an effective yet much smaller model, which is more practical for realworld application scenarios. The experiments on standard benchmarks, including the IIIT-5K, Street View Text and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results